Recent Finacing
Recent Raise
Onco-NX, a University of Salford spin-out in Salford, UK, develops DT‑Diaphorase‑activated prodrugs targeting solid tumours, advancing three candidates through preclinical evaluation toward partnering and licensing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor